Technology

Technology, Artificial Intelligence,Blockchain, Generative AI,

Business

Business, Automobile, Banking, Energy, Merger & Acquisition, Startups, Telecommunications,

GAMING & GADGETS

Gaming & Gadgets, gadgets, Online Gaming,

SCIENCE

Science

UPES Runway Invests ₹25 Lakh in Reagvis Labs to Advance AI‑Powered Digital Trust

UPES Runway Invests ₹25 Lakh in Reagvis Labs to Advance AI‑Powered Digital Trust
Dr. Sachin Chaudhary, Co-founder, Reagvis Labs

UPES Runway, the startup incubator at UPES, announced an investment of ₹25 lakh through equity participation in Reagvis Labs, a deep-tech startup developing indigenous artificial intelligence solutions for digital trust, including deepfake detection, document forgery detection, digital identity verification and digital content authentication. The investment is part of UPES Runway’s initiative to identify and support promising AI-native and AI-driven ventures through capital, mentorship and access to the wider startup and investor ecosystem.

Founded in 2025 by Dr. Sachin Chaudhary and Dr. Praful Hambarde, Reagvis Labs grew out of an academic collaboration between the two researchers during their PhD journey. Working in artificial intelligence and computer vision, the founders witnessed the emerging challenges around the misuse of generative AI to create deepfakes, forged documents, synthetic identities and misleading digital content. Reagvis Labs was created to address challenges such as deepfakes, forged documents and synthetic identities, with capabilities spanning media manipulation detection, identity and content verification, and KYC across image, video and audio, by building AI-led technologies that strengthen trust in the digital ecosystem.

Rahul Nainwal, CEO, Runway Incubator and Dean, School of Business, UPES, said, “The next phase of AI innovation will not only be about what artificial intelligence can create, but also about whether we can trust what it creates. Reagvis Labs is working on a problem that will become increasingly important as synthetic content becomes more sophisticated and widespread. Through The Pitch, our objective is to identify such AI-led ventures with strong technology depth and meaningful real-world applications and give founders the capital and ecosystem support they need to build and scale.”

Dr. Sachin Chaudhary, Co-founder, Reagvis Labs, said, “Reagvis began with our belief that trust must become a fundamental layer of the AI-powered digital world. As generative technologies grow more powerful, the ability to distinguish authentic content from manipulated or synthetic content will become increasingly important for businesses, governments and individuals. The investment and support from UPES Runway will help us strengthen our technology, accelerate development and take our digital-trust solutions to a wider set of real-world applications.”

Through The Pitch 3.0, UPES Runway plans to support 10 innovators this year, with an investment of around ₹25 lakh per startup, and the potential for higher investment in exceptional AI-led ventures, subject to evaluation and approval. Pitch 3.0 recently concluded its Delhi leg, which attracted more than 20 applications and brought seven shortlisted startups before investors, mentors and UPES leaders. The ventures represented a wide range of sectors, including AI image recognition, fintech, edtech, disaster management, fleet technology, quantum computing and deep tech, reflecting the breadth of AI-led innovation emerging from India’s startup ecosystem. Startups - Arthik AI, StoreLink and Memintel were shortlisted in the Delhi round. The next leg of The Pitch is being planned in Bengaluru, as UPES Runway continues to identify and invest in niche AI businesses across different markets.

Through the Runway Incubator, UPES is also advancing its larger vision as an AI-first university, connecting academic and technological capabilities with entrepreneurship, funding and market opportunities. The initiative seeks to enable founders to take AI-led solutions beyond the laboratory or prototype stage and build ventures capable of addressing emerging industry and societal challenges.

Launched in 2021, Runway has grown into a platform for entrepreneurial development at UPES. In about five years, more than 200 startups have been incubated through Runway in association with DST-TIBI, MeitY, Shell E4, MaXcel Accelerator and Global University Systems.

For more information, please visit: runwayincubator.com

About UPES:

Established through the UPES Act, 2003, of the State Legislature of Uttarakhand, UPES is a top-ranked, UGC-recognised, private university. As per the National Institutional Ranking Framework (NIRF) 2025, the Ministry of Education, Government of India, UPES has been ranked 45 among universities, with a rank of 18 in Law, 36 in Management, and a rank of 43 in Engineering. As per the Times Higher Education (THE) World University Rankings 2026, UPES now stands in the 501-600 band globally and 5th in India, improving from 7th in 2025. Notably, in Research Quality, UPES jumped 57 positions in just one year to be ranked 299 globally. In addition to this, the university has been ranked the No.1 private university in academic reputation in India by the QS World University Rankings 2026. It is among the top 2% of universities in the world.

UPES has received 5 stars on Employability (placements) by the globally acclaimed QS Rating. 50+ faculty members from UPES feature among the world’s top 2% researchers as per the Stanford University list.

UPES offers graduate and postgraduate programs through its seven schools: School of Advanced Engineering, School of Computer Science, School of Design, School of Law, School of Business, School of Health Sciences & Technology, and School of Liberal Studies and Humanities. The UPES family includes 20000+ students, 1,500+ faculty and staff members, and a thriving community of 40000+ alumni that work across sectors in marquee brands like EY, KPMG, Bain and Co., McKinsey & Company, Capgemini, Google, Microsoft, Oracle, Nestle, ITC, Adani Power, ONGC, GMR, TCS, Wipro, Infosys, Amazon, Flipkart, Accenture, Deloitte and more.

Pixxel’s $100M Boost Fuels Hyperspectral Satellite Revolution

Pixxel’s $100M Boost Fuels Hyperspectral Satellite Revolution
Image ~ Pixxel.com

Pixxel, the Google-backed Indian space-tech startup, has raised $100 million in a Series C round led by Temasek and Seraphim, marking India’s largest-ever private space-tech funding. This brings Pixxel’s total capital raised to $195 million and values the company between $400–500 million.

The $100M raise stands as India’s largest-ever space-tech funding round, underscoring Pixxel’s transition into its next growth phase as it expands across the entire space-tech value chain.

The fundraise arrives amid strong tailwinds for Pixxel. In just two years, the company has deployed six Firefly satellites to build the world’s highest-resolution commercial hyperspectral constellation, launched its Aurora Earth intelligence platform, and secured contracts with NASA and the NRO. It has also triumphed in multiple iDEX challenges from India’s Ministry of Defence, unveiled an orbital data-centre demonstration satellite, and been chosen to spearhead India’s first public-private Earth observation constellation of 12 satellites under IN-SPACe.

Key Funding Details

  • Round size: $100 million (Series C)
  • Lead investors: Temasek (Singapore) and Seraphim (UK)
  • Other participants: Radical Ventures, growX Ventures, 360 ONE Asset, IMM Investment
  • Total funding to date: $195 million
  • Valuation: Estimated between $400–500 million

Strategic Expansion Plans

  • Satellite Fleet Growth: Expansion of the Firefly hyperspectral constellation, upcoming Honeybee satellites, and sub-metre resolution satellites.
  • Aurora Platform: Scaling its Earth intelligence software, which integrates satellite data with AI for actionable insights.
  • Planetary Infrastructure Vision: Combining sensors, satellites, and AI to create a “health monitor for the planet.”

Why This Matters

  • Largest space-tech fundraise in India: Positions Pixxel as the most well-funded Indian space startup, surpassing peers like Skyroot Aerospace.
  • Global relevance: Hyperspectral imaging provides data beyond conventional satellite imagery, useful for climate monitoring, agriculture, defence, and resource management.
  • Sovereign capability: Nations can leverage Pixxel’s systems for independent space missions and intelligence.

Comparison with Peers

PixxelSkyroot Aerospace
$195M total funding$160M total funding
Focus: Hyperspectral satellites + AI Earth intelligenceFocus: Launch vehicles (rockets)
Valuation: $400–500MValuation: $1.1B (unicorn)
Backers: Temasek, Seraphim, GoogleBackers: GIC, Lenskart’s Peyush Bansal

Challenges Ahead 

  • Capital intensity: Satellite manufacturing and launches require sustained funding.
  • Global competition: Rivals like Planet Labs and Satellogic already dominate hyperspectral imaging.
  • Regulatory hurdles: India’s evolving private space policy could affect timelines and sovereign contracts.
  • Execution risk: Scaling Aurora software and satellite fleets simultaneously is complex.

How Hospital Cost Estimates Can Guide Your Medical Insurance Coverage

How Hospital Cost Estimates Can Guide Your Medical Insurance Coverage

Hospital cost estimates can help you judge whether your medical insurance coverage is likely to match the expenses you may incur during hospitalisation. By looking at treatment, room, procedure and related hospital charges, you can make a more informed decision about the level of cover you may need.

For people in India, this information is useful because treatment costs can vary by city, hospital category and type of care. A realistic estimate gives you a starting point for reviewing your sum insured and policy limits.
A hospital estimate gives an approximate view of what an admission or treatment may cost. It is not a final bill, but it can show the scale of hospitalisation before treatment starts.

The estimate may include:
  • Room charges
  • Doctor fees
  • Procedure or surgery charges
  • Diagnostic costs
  • Medicines and consumables
  • Nursing charges
Looking at these components helps you understand whether your insurance limit appears proportionate to hospital expenses.

How Estimates Help You Review the Sum Insured

The sum insured is the maximum amount available under the policy, subject to its terms. Hospital cost estimates can help you assess whether that limit matches the types of expenses you may incur.

If expected hospital charges are close to the available cover, there may be limited room for related costs during the policy period. This is why people reviewing their health care coverage can benefit from comparing the policy limit with realistic hospital cost information rather than considering the sum insured in isolation.

Why Room Charges Need Attention

Room charges can form a meaningful part of the hospital bill, particularly when the admission lasts several days. Some policies may also link room eligibility to other payable expenses, depending on the wording.

A cost estimate can help you check:
  • The room category being considered
  • Daily room charges
  • Whether the policy has a room-rent condition
  • Whether related charges are linked to room eligibility
  • The likely effect of choosing a different room category
This comparison can help prevent a mismatch between the selected hospital room and the amount the policy may recognise.

How Procedure Costs Affect Coverage Needs

Hospital procedures can differ in complexity, equipment requirements and length of stay. Their expected cost can therefore be useful when judging whether the existing insurance limit is adequate.

A procedure estimate may show:
  • Operation theatre charges
  • Surgeon and anaesthetist fees
  • Medical equipment costs
  • Implant or device charges, where relevant
  • Monitoring and recovery expenses
Reviewing these items alongside the policy can help you see whether any sub-limits, exclusions or specific conditions could affect the amount payable.

Why City and Hospital Types Can Change Estimates

Hospital charges are not uniform across India. Costs may differ between metropolitan cities, smaller cities, private hospitals, speciality centres and other facilities.

This matters because a sum insured that appears comfortable in one location may feel less adequate in a higher-cost setting. If you expect treatment in a particular city or hospital network, local cost estimates can provide more relevant information than broad assumptions.

The purpose is not to predict the final bill exactly but to understand the likely cost environment before deciding whether the available cover seems sufficient.

How to Compare Estimates with Policy Limits

Once you have a hospital estimate, compare it with the policy terms rather than only the headline sum insured. The amount payable can depend on conditions within the policy.

Check whether the estimate includes expenses affected by:
  • Room-rent limits
  • Procedure-specific sub-limits
  • Co-payment clauses
  • Deductibles
  • Non-medical expenses
  • Waiting periods
  • Exclusions
This comparison helps reveal where the policy may cover the estimated expense fully, partly or not at all, subject to claim assessment.

Why One Estimate May Not Be Enough

A single hospital estimate may not represent every possible treatment situation. Costs can vary depending on the diagnosis, duration of admission, medical complications, hospital choice and treatment approach.

It can therefore be useful to review more than one cost range when assessing coverage. The aim is to understand whether the policy has enough room to absorb variation rather than matching one estimate exactly.

This approach gives a more realistic view of how the insurance limit may perform when hospital expenses differ from the initial estimate.

Conclusion

Hospital cost estimates can make medical insurance coverage easier to assess because they connect the policy limit with realistic treatment expenses. They help you review room charges, procedure costs, hospital location, sub-limits and other conditions that can affect the amount available during a claim.

Rather than choosing cover only by looking at a headline sum insured, comparing it with likely hospital costs gives you a clearer basis for judging adequacy. The final decision should still reflect the policy wording, because actual claim payments depend on the terms, exclusions and conditions that apply.

Quantum Leap: IBM’s Nighthawk r2 Breaks Barriers

Quantum Leap: IBM’s Nighthawk r2 Breaks Barriers

IBM has just unveiled the Nighthawk r2, its fastest quantum processor to date, capable of executing over 100,000 circuits per second—25 times faster than the Heron fleet—thanks to a groundbreaking dissipative qubit reset system. With 120 programmable qubits and advanced couplers, it marks a major 2026 milestone in IBM’s quantum roadmap.

Key Highlights of IBM Nighthawk r2

  • Fastest IBM processor: Executes 100,000+ circuits per second, a 25x speed boost over Heron (~4,000 circuits/sec).
  • Qubit architecture: 120 programmable qubits, 218 inter-qubit couplers, 120 independent reset elements (458 total quantum elements).
  • Dissipative reset innovation: Drops qubit relaxation time (T1) from ~200 µs to ~25 ns, reduces idle times to ~1 µs, cuts initialization errors by ~25x.
  • Complex circuit capability: Accurate execution of circuits with 7,500+ gates, a critical 2026 roadmap milestone.
  • Applications: Real-time simulations, quantum error correction, and fault-tolerant computing research.

Comparison: Nighthawk r2 vs Heron

FeatureNighthawk r2Heron
Qubit Count120133 (Heron fleet)
Circuit Throughput100,000+/sec~4,000/sec
Reset SystemDissipative reset (25 ns T1)Conditional reset (~200 µs T1)
Initialization Error~25x lowerHigher
Gate FidelityMaintains Heron-classStandard
Roadmap Milestone7,500+ gate circuits~1,000–2,000 gate circuits

Strategic Context

  • Global Race: IBM’s Nighthawk r2 positions it ahead of rivals by combining speed, scale, and error correction.
  • India’s Relevance: With Amaravati’s upcoming IBM Quantum System Two (156-qubit), India integrates into IBM’s global quantum ecosystem.
  • Future Outlook: IBM’s roadmap targets fault-tolerant quantum computing by 2029, with modular cryogenic systems already being tested.

Risks & Challenges

  • Hardware complexity: 458 physical quantum elements increase engineering demands.
  • Error correction gap: Scaling error correction to thousands of qubits remains unresolved.
  • Global competition: Chinese labs and Google are already testing 1,000+ qubit systems, so IBM must accelerate deployment.

China’s UBTECH Lands $13.9M for Breakthrough Robot Development

China’s UBTECH Lands $13.9M for Breakthrough Robot Development

Chinese robotics firm UBTECH has raised $13.9 million in September 2026 to accelerate development of humanoid and quadruped robots. This complements its larger $139M round earlier this month, signaling a dual-track strategy to scale production while innovating new robot types.

Key Funding Details
  • Amount raised: $13.9M (September 2026)
  • Purpose:
    • Develop high-power-density integrated joint modules
    • Build industrial-operation humanoid robots
    • Create consumer-grade humanoid robots
    • Design heavy-load and explosion-proof quadruped robots
  • Cumulative financing: Several hundred million yuan to date
UBTECH Robotics, founded in 2012 by James Zhou (Zhou Jian) in Shenzhen, China, is a publicly listed humanoid and service robotics company that has raised approximately $1.34 billion across six funding rounds from investors including Tencent, Qiming Venture Partners, CDH Investments, and others. It is headquartered in Shenzhen, Guangdong, and became the first humanoid robotics company to list on a major stock exchange (HKEX: 9880) in December 2023. 

UBTECH’s Robotics Portfolio

China’s UBTECH Lands $13.9M for Breakthrough Robot Development
  • Walker series: Full-size humanoid robots for industrial automation, logistics, and inspection
  • Walker C1: Targeted at services, education, and research
  • U1 series: Consumer and companion robots
  • Quadruped robots: Heavy-load, explosion-proof designs for hazardous environments

Industry Context

China’s UBTECH Lands $13.9M for Breakthrough Robot Development
  • China’s humanoid robotics boom: VC investment hit $8.7B in 2026 YTD, double 2025’s record
  • UBTECH’s growth:
    • Revenue H1 2026: RMB 1.27B ($188M), more than double YoY
    • Sold 921 full-size humanoid robots in H1 2026
    • Revenue from humanoid robots rose 1,445% YoY

Challenges & Risks

  • Reliability: Robots must adapt beyond structured factory settings
  • Profitability: Despite revenue growth, UBTECH posted a net loss of RMB 339M in H1 2026
  • Scaling hurdles: Moving from pilot deployments to large-scale commercial use remains critical

Global & Local Impact

  • Industrial automation: Robots could accelerate manufacturing efficiency
  • Education robotics: May enter classrooms at lower cost
  • Hazardous environment quadrupeds: Could support mining, defence, and disaster response

Market Reports

Market Report & Surveys
IndianWeb2.com © all rights reserved